Skip to main content
SpringerLink
Log in

A Qualitative Investigation of Antiretroviral Therapy Among Injection Drug Users

  • Published:
AIDS and Behavior Aims and scope Submit manuscript

Abstract

Recent advances in antiretroviral therapy for HIV/AIDS have improved the quality of life and life expectancies of many with this fatal disease. Nevertheless, a significant proportion of individuals from disadvantaged groups, which traditionally have had difficulty accessing high-quality health care in the United States, have not benefited from these treatments. For example, injection drug users (IDUs), now a principal source of new cases of AIDS, have received antiretroviral therapy at significantly lower rates than other groups. Whereas numerous studies have described this group quantitatively, few studies have examined in depth the influences that lead to IDUs' problematic relationship with HIV/AIDS treatment. The study described here is based on a longitudinal survey of 516 IDUs. A quantitative analysis was conducted with 103 HIV-positive IDUs and an in-depth qualitative analysis was performed with a subsample of 34 HIV-positive IDUs. This paper presents findings on the consequences of antiretroviral therapy use and nonuse among these individuals, focusing on their perspectives regarding this treatment regimen. Findings suggest that problematic access to, and usage of, antiretroviral therapy is related to wider societal problems of drug abuse, access to health care and housing, and the social and historical divisions that impact the lives of IDUs and their communities. Efforts to improve the availability and the adherence to antiretroviral therapy among IDUs should involve these individuals as a critical component in the design of culturally appropriate and supportive health care services.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • American Medical Association (2001). HIV and heroin interactions. Journal of the American Medical Association, 286, 295.

    Google Scholar 

  • Bangsberg, D., and Moss, A. (1999). When should we delay highly active antiretroviral therapy? Journal of General Internal Medicine, 14, 464-468.

    Google Scholar 

  • Bangsberg, D., Tulsky, J., Hecht, F., and Moss, A. (1997). Protease inhibitors in the homeless. Journal of the American Medical Association, 278, 63-65.

    Google Scholar 

  • Bassetti, S., Battegay, M., Furrer, H., Rickenbach, M., Flepp, M., Kaiser, L., Telenti, A., Vernazza, P., Bernasconi, E., and Sudre, P. (1999). Why is highly active antiretroviral therapy (HAART) not prescribed or discontinued? Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 21, 114-119.

    Google Scholar 

  • Bassetti, S., Battegay, M., and Sudre, P. (2000). Access to antiretroviral therapy. Journal of the American Medical Association, 283, 883-884.

    Google Scholar 

  • Broadhead, R., Heckathorn, D., Grund, J., Stern, S., and Anthony, D. (1995). Drug users versus outreach workers in combating AIDS: Preliminary results of peer-driven intervention. Journal of Drug Issues, 25, 531-564.

    Google Scholar 

  • Carlson, R., Wang, J., Siegal, H., Falck, R., and Guo, J. (1994). An ethnographic approach to targeted sampling: Problems and solutions in AIDS prevention research among injection drug users and crack cocaine users. Human Organization, 52, 279-286.

    Google Scholar 

  • Celentano, D. D., Vlahov, D., Cohn, S., Shadle, V. M., Obasanjo, O., and Moore, R. D. (1998). Self-reported antiretroviral therapy in injection drug users. Journal of the American Medical Association, 280, 544-546.

    Google Scholar 

  • Centers for Disease Control and Prevention. (1998). Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents. Mobidity and Mortality Weekly Reports, 47, 43-82.

    Google Scholar 

  • Centers for Disease Control and Prevention. (2000). HIV/AIDS among racial/ethnic minority men who have sex with men–United States 1989–1998. Mobidity and Mortality Weekly Reports, 49, 4-11.

    Google Scholar 

  • Cherubin, C., and Sapira, J. (1993). The medical complications of drug addiction and the medical assessment of the intravenous drug user: 25 years later. Annals of Internal Medicine, 119, 1017-1028.

    Google Scholar 

  • Chesney, M., Ickovics, J., Hecht, F., and Sikipa, G. (1999). Adherence: A necessity for successful HIV combination therapy. AIDS, 13, 271-278.

    Google Scholar 

  • Connors, M. (1995). The politics of marginalization: The appropriation of AIDS prevention messages among injection drug users. Culture, Medicine and Psychiatry, 19, 425-452.

    Google Scholar 

  • Crespo-Fierro, M. (1997). Compliance/adherence and care management in HIV disease. Journal of the Association of Nurses in AIDS Care, 8, 43-54.

    Google Scholar 

  • Crystal, S. (1992). Health-care barriers and utilization patterns among intravenous-drug users with HIV disease. AIDS and Public Policy Journal, 7, 187-198.

    Google Scholar 

  • Crystal, S., Sambamoorthi, U., and Merzel, C. (1995). The diffusion of innovation in AIDS treatment: Zidovudine use in two New Jersey cohorts. Health Services Research, 30, 593-614.

    Google Scholar 

  • Deeks, S. G., Grant, R. M., Beatty, G. W., Horton, D., Demar, J., and Eastman, S. (1998). Activity of ritonavir plus saquinavir-containing regimen with virologic evidence of indinavir or ritonavir failure. AIDS, 12, 97-102.

    Google Scholar 

  • Demas, P., Schoenbaum, E., Hirky, A., Wills, T., Doll, L., Hartel, D., and Klein, R. (1998). The relationship of HIV treatment acceptance and adherence to psychosocial factors among injecting drug users. AIDS and Behavior, 2, 283-292.

    Google Scholar 

  • Emerson, R., Fretz, R., and Shaw, L. (1995). Writing ethnographic fieldnotes. Chicago: University of Chicago Press.

    Google Scholar 

  • Fee, E., and Krieger, N. (1993). Thinking and rethinking AIDS: Implications for health policy. International Journal of Health Services, 23, 323-346.

    Google Scholar 

  • Ferzacca, S. (2000). “Actually, I don't feel that bad”: Managing diabetes and the clinical encounter. Medical Anthropology Quarterly, 14, 28-50.

    Google Scholar 

  • Friedman, P., McCullough, D., and Saitz, R. (2001). Screening and intervention for illicit drug abuse: A national survey of primary care physicians and psychiatrists. Archives of Internal Medicine, 161, 248-251.

    Google Scholar 

  • Friedman, S., de Jong, W., and Des Jarlais, D. (1988). Problems and dynamics of organizing intravenous drug users for AIDS prevention. Health Education Research, 3, 49-57.

    Google Scholar 

  • Friedman, S., Neaigus, A., Jose, B., Curtis, R., Goldstein, M., Sotheran, J., Wenston, J., Latkin, C., and Des Jarlais, D. (1997). Network and sociohistorical approaches to the HIV epidemic among drug injectors. In J. Catalan, L. Sherr, and B. Hedge (Eds.), The impact of AIDS: Psychological and social aspects of HIV infection (pp. 89-113). Amsterdam: Harwood.

    Google Scholar 

  • Friedman, S., Wainberg, M., and Drucker, E. (1998a). Therapeutic ethics and communities at risk in the presence of potential mutation to resistant strains to HIV antiviral medications. AIDS, 12, 2089-2093.

    Google Scholar 

  • Friedman, S., Jose, B., Neaigus, A., Goldstein, M., Mota, P., Curtis, R., Ildefonso, G., and DesJarlais, D. (1998b). Multiple racial ethnic subordination and HIV among drug injectors. In M. Singer (Ed.), The political economy of AIDS (pp. 105-127). Amityville, NY: Baywood.

    Google Scholar 

  • Friedman, S., Curtis, R., Neaigus, A., Jose, B., and Des Jarlais, D. (1999). Social networks, drug injectors' lives and HIV/AIDS. New York: Kluwer Academic/Plenum.

    Google Scholar 

  • Hartnoll, R. (1992). Research and the help-seeking process. British Journal of Addiction, 87, 429-437.

    Google Scholar 

  • Hassin, J. (1994). Living a responsible life: The impact of AIDS on the social identity of intravenous drug users. Social Science and Medicine, 39, 391-400.

    Google Scholar 

  • Heckathorn, D. (1997). Respondent-driven sampling: A new approach to the study of hidden populations. Social Problems, 44, 174-199.

    Google Scholar 

  • Hoffmann, J. P., Su, S. S., and Pach, A. (1997). Changes in network characteristics and HIV risk behavior among injection drug users. Drug and Alcohol Dependence, 46, 41-51.

    Google Scholar 

  • Holmberg, S. (1996). The estimated prevalence and incidence of HIV in 96 large U.S. metropolitan areas. American Journal of Public Health, 85, 642-654.

    Google Scholar 

  • Hunt, L., Jordan, B., Irwin, S., and Browner, C. (1989). Compliance and the patient's perspective: Controlling symptoms in everyday life. Culture, Medicine and Psychiatry, 13, 315-334.

    Google Scholar 

  • Inciardi, J., Martin, S., and Scarpitti, F. (1994). Appropriateness of assertive case management for drug-involved prison releasees. Journal of Case Management, 3, 145-149.

    Google Scholar 

  • Johnson, R. A., Gerstein, D. R., Pach, A., Cerbone, F. G., and Brown, J. (2002). HIV risk behaviors in drug injector networks: Iimplications of injection partner mixing and partnership characteristics. Addiction, 97, 1011-1024.

    Google Scholar 

  • Jones, J. H. (1993). Bad blood: The Tuskegee syphilis experiment. New York: Free Press.

    Google Scholar 

  • Karon, J. M., Fleming, P.L., Steketee, R. W., De Cock, K. M. (2001). HIV in the United States at the Turn of the Century: An epidemic in Transition. American Journal of Public Health, 91, 1060-1068.

    Google Scholar 

  • Kissinger, P., Cohen, D., Brandon, W., Rice, J., Morse, A., and Clark, R. (1995). Compliance with public sector HIV medical care. Journal of the National Medical Association, 87, 19-24.

    Google Scholar 

  • Klovdahl, A. (1989). Urban social networks: Some methodological problems and possibilities. In M. Kochen (Ed.), The small world (pp. 176-210). Norwood, NJ: Ablex.

    Google Scholar 

  • Leukefeld, C., Logan, T., Martin, S., Durvis, R., and Farabee, D. (1998). A health services use framework for drug-abusing offenders. American Behavioral Scientist, 41, 1123-1135.

    Google Scholar 

  • Maisels, L., Steinberg, J., and Tobias, C. (2001). An investigation of why eligible patients do not receive HAART. AIDS Patient Care and STDs, 15, 185-191.

    Google Scholar 

  • Mayer, K. (1999). Combination antiretroviral chemotherapy: Shifting paradigms and evolving praxis. In D. Ostrow and S. Kalichman (Eds.), Psychosocial and public health impacts of new HIV therapies (pp. 1-26). New York: Kluwer Academic/Plenum.

    Google Scholar 

  • McLaughlin, D. C., McKenna, H., and Leslie, J. C. (2000). The perceptions and aspirations illicit drug users hold toward health care staff and the care they receive. Journal of Psychiatric and Mental Health Nursing, 7, 435-441.

    Google Scholar 

  • Mocroft, A., Madge, S., Johnson, A., Lazzarin, A., Clumeck, N., Goebel, F. D., Viard, J. P., Gatell, J., Blaxhult, A., and Lundgren, J. (1999). A comparison of exposure groups in the EuroSIDA study: Starting highly active antiretroviral therapy, response and survival. Journal of Acquired Immune Deficiency Syndromes, 22, 369-378.

    Google Scholar 

  • Mostashari, F., Riley, E., Selwyn, P., and Altice, F. (1998). Acceptance and adherence of antiretroviral therapy among HIV-infected women in a correctional facility. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 18, 341-348.

    Google Scholar 

  • O'Connor, P., Molde, S., Henry, S., Shockcor, W., and Schottenfeld, R. (1992). Human immunodeficiency virus infection in intravenous drug users: A model for primary care. American Journal of Medicine, 93, 382-386.

    Google Scholar 

  • O'Connor, P., Selwyn, P., and Schottenfeld, R. (1994). Medical care for injection drug users with human immunodeficiency virus infection. New England Journal of Medicine, 331, 450-459.

    Google Scholar 

  • Palella, F., Delaney, K., Moorman, A., Loveless, M., Fuhrer, J., Satten, G., Ashman, D., and Holmberg, S. (1998). Declining morbidity and mortality among patients with advanced HIV infection. New England Journal of Medicine, 338, 853-860.

    Google Scholar 

  • Pequegnat, W., and Stover, E. (1999). Behavioral research needs and challenges of new treatments: AIDS as a chronic illness. In D. Ostrow and S. Kalichman (Eds.), Psychosocial and public health impacts of new HIV therapies (pp. 183-191). New York: Kluwer Academic/Plenum.

    Google Scholar 

  • Pescosolido, B., Wright, E. R., Alegria, M., and Vera, M. (1998). Social networks and patterns of use among the poor with mental health problems in Puerto Rico. Medical Care, 36, 1057-1072.

    Google Scholar 

  • Piette, J., Mor, V., Mayer, K., Zierler, S., and Wachtel, T. (1992). The effects of immune status and race on health service use among people with HIV disease. American Journal of Public Health, 83, 510-514.

    Google Scholar 

  • Rabkin, J., and Chesney, M. (1999). Treatment adherence to HIV medications: The Achilles heel of the new therapeutics. In D. Ostrow and S. Kalichman (Eds.), Psychosocial and public health impacts of new HIV therapies (pp. 61-79). New York: Kluwer Academic/Plenum.

    Google Scholar 

  • Rhodes, T. (1994). HIV, outreach, peer education and community change. Health Education Journal, 53, 92-99.

    Google Scholar 

  • Roberts, K. (2000). Barriers to and facilitators of HIV-positive patients' adherence to antiretroviral treatment regimen. AIDS Patient Care and STDs, 14, 155-168.

    Google Scholar 

  • Rockwell, R., Friedman, S., Sotheran, J., and Des Jarlais, D. (1998). Medical access for injecting drug users. In M. Singer (Ed.), The political economy of AIDS (pp. 131-147). Amityville, NY: Baywood.

    Google Scholar 

  • Ruiz, L., Martinez-Picado, J., Romeru, J., Paredes, R., Mohd, K., Marfil, S., Negrado, E., Sierra, G., Tural, L., and Cloet, B. (2000). Structured treatment interruption in chronically HIV-1 infected patients after long-term viral suppression. AIDS, 14, 397-403.

    Google Scholar 

  • Selwyn, P., Alcabes, P., Hartel, D., Buono, D., Schoenbaum, E., Klein, R., Daveny, K., and Friedland, G. (1992). Clinical manifestations and predictors of diseases progression in drug users with human immunodeficiency virus infection. New England Journal of Medicine, 327, 1697-1703.

    Google Scholar 

  • Shapiro, M., Morton, C., McCaffrey, D., Senterfitt, J., Fleishman, J., Perlman, J., Athey, L., Keesey, J.,Goldman, D., Berry, S., and Bozzette, S. (1999). Variations in the care of HIV-infected adults in the United States. Journal of the American Medical Association, 281, 2305-2315.

    Google Scholar 

  • Singer, M. (1998). Forging a political economy of AIDS. In M. Singer (Ed.), The political economy of AIDS (pp. 3-31). Amityville, NY: Baywood.

    Google Scholar 

  • Solomon, L., Frank, R., Vlahov, D., and Astemborski, J. (1991). Utilization of health services in a cohort of intravenous drug users with known HIV-1 serostatus. American Journal of Public Health, 81, 1285-1290.

    Google Scholar 

  • Stein, M. A., O'Sullivan, P. S., Ellis, P., Perrin, H., and Wartenberg, A. (1993). Utilization of medical services by drug abusers in detoxification. Journal of Substance Abuse, 5, 187-193.

    Google Scholar 

  • Strathdee, S. A., Palepu, A., Cornelisse, P. G., Yip, B., O'Shaughnessy, M. V., Montaner, J. S., Schechter, M. T., and Hogg, R. S. (1998). Barriers to use of free antiretroviral therapy in injection drug users. Journal of American Medical Association, 280, 547-549.

    Google Scholar 

  • Strauss, A., Corbin, J., Fagerhaugh, S., Glaser, B., Maines, D., Suczek, B., and Wiener, C. (1984). Chronic illness and the quality of life. St. Louis: Mosby.

    Google Scholar 

  • Thomas, S., and Quinn, S. (1991). The Tuskegee Syphilis Study, 1932 to 1972: Implications for HIV education and AIDS risk education programs in the Black community. American Journal of Public Health, 81, 1498-1504.

    Google Scholar 

  • Trostle, J., Hauser, A., and Susser, I. (1983). The logic of noncompliance: Management of epilepsy from the patient's point of view. Culture, Medicine and Society, 7, 35-56.

    Google Scholar 

  • U.S. Public Health Service. (1997). HIV prevention bulletin: Medical advice for persons who inject illicit drugs. Washington, DC: U.S. Government Printing Office [Available at http://www.cdc.gov/nchstp/hiv___aids/pubs/hiv/prev.txt].

    Google Scholar 

  • van der Werf, M. J., Schnikel, J., van Santen, G., Vergouwe, I., Wix, R., and van Ameijden, E. (1999). Highly active antiretroviral therapy among drug users in Amsterdam: Self-perceived reasons for not receiving therapy. AIDS, 13, 1280-1281.

    Google Scholar 

  • Wainberg, M. A., and Friedland, G. (1998). Public health implications of antiretroviral therapy and HIV drug resistance. Journal of the American Medical Association, 279, 1977-1983.

    Google Scholar 

  • Waterston, A. (1997). Anthropological research and the politics of HIV prevention: Towards a critique of policy and priorities in the age of AIDS. Social Science and Medicine, 44, 1381-1391.

    Google Scholar 

  • Watters, J., and Biernacki, P. (1975). Targeted sampling: Options for the study of hidden populations. Social Problems, 36, 416-430.

    Google Scholar 

  • Weidle, P., Holmberg, S., and DeCock, K. (1999). Changes in HIV and AIDS epidemiology from new generation antiretroviral therapy. AIDS, 13, 61-68.

    Google Scholar 

  • Weissman, G., Melchior, L., Huba, G., Altice, F., Booth, R., Cottler, L., Genser, S., Jones, A., McCarthy, S., Needle, R., and Smerck, G. (1995). Women living with substance abuse and HIV disease: Medical care access issues. Journal of American Medical Women's Association, 50, 115-120.

    Google Scholar 

  • White House Fact Sheet. (1998). President Clinton announces new racial and ethnic health disparities initiative. Internet Announcement, HHS Press Office, February 21, 1998 [Available at http://www.raceandhealth.hhs.gov/sidebars/sbinitPres.htm].

Download references

Author information

Authors and Affiliations

  1. Department of Substance Abuse, Mental Health, and Criminal Justice Studies, NORC at the University of Chicago, Washington Office, Washington, DC, 20036

    Alfred Pach III, Felicia Gray Cerbone & Dean R. Gerstein

Authors
  1. Alfred Pach III
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Felicia Gray Cerbone
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Dean R. Gerstein
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Dean R. Gerstein.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pach, A., Cerbone, F.G. & Gerstein, D.R. A Qualitative Investigation of Antiretroviral Therapy Among Injection Drug Users. AIDS Behav 7, 87–100 (2003). https://doi.org/10.1023/A:1022517608578

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1022517608578

Search

Navigation